Hubungan Usia dan Paritas dengan Keparahan Mioma Uteri di RSUD di Kwaingga, Keerom, Papua
DOI:
https://doi.org/10.69688/juksit.v5i1.1.275Keywords:
Usia, Paritas, Keparahan Mioma Uteri, Mioma Uteri, Pasien Rawat InapAbstract
Mioma uteri merupakan tumor jinak uterus yang dapat menimbulkan manifestasi klinis dengan tingkat keparahan yang berbeda. Bukti mengenai faktor yang berhubungan dengan keparahan pada rumah sakit daerah di Papua masih terbatas. Penelitian ini bertujuan menganalisis hubungan usia dan paritas dengan tingkat keparahan mioma uteri pada pasien rawat inap di RSUD Kwaingga, Kabupaten Keerom, periode 2020–2025. Penelitian menggunakan desain observasional analitik retrospektif berbasis rekam medis dengan total sampling terhadap 90 kasus yang memenuhi kriteria. Data dianalisis secara deskriptif dan bivariat menggunakan Fisher’s exact test untuk usia dan uji chi-square untuk paritas dengan tingkat kemaknaan p<0,05. Kelompok usia >40 tahun merupakan kelompok terbesar (58,9%), multipara 53,3%, dan kasus tidak parah 73,3%. Usia berhubungan secara bermakna dengan tingkat keparahan mioma uteri (p<0,001), sedangkan paritas tidak menunjukkan hubungan bermakna (p=0,188). Pada kelompok usia >40 tahun, proporsi kasus parah mencapai 43,4%. Temuan ini menunjukkan bahwa pada populasi yang diteliti, variasi keparahan lebih terkait dengan usia dibandingkan paritas. Penelitian menyediakan bukti lokal mengenai karakteristik pasien mioma uteri di rumah sakit daerah Papua dan dapat menjadi dasar pengembangan penelitian dengan variabel klinis dan patologis yang lebih lengkap.
References
C. Wu et al., “The epidemiology of uterine fibroids: global disease burden from 1990 to 2021 and future trend predictions,” Front. Reprod. Heal., vol. 7, 2025, doi: 10.3389/frph.2025.1629834.
I. O. Aninye and M. H. Laitner, “Uterine Fibroids: Assessing Unmet Needs from Bench to Bedside,” J. Women’s Heal., vol. 30, no. 8, pp. 1060–1067, 2021, doi: 10.1089/jwh.2021.0280.
D. L. Chandrakumar, M. Aref-Adib, and F. Odejinmi, “Advancing women’s health: The imperative for public health screening of uterine fibroids for personalized care,” Eur. J. Obstet. Gynecol. Reprod. Biol., vol. 299, pp. 266–271, 2024, doi: 10.1016/j.ejogrb.2024.06.014.
E. K. M. Edzie et al., “Age of first diagnosis and incidence rate of uterine fibroids in Ghana. A retrospective cohort study,” PLoS One, vol. 18, no. 3 March, 2023, doi: 10.1371/journal.pone.0283201.
B. Li, F. Wang, L. Chen, and H. Tong, “Global epidemiological characteristics of uterine fibroids,” Arch. Med. Sci., vol. 19, no. 6, pp. 1802–1810, 2023, doi: 10.5114/aoms/171786.
A. L. Keizer, A. Semmler, H. S. Kok, P. J. M. van Kesteren, J. A. F. Huirne, and W. J. K. Hehenkamp, “Modifiable prognostic factors in uterine fibroid development: a systematic review of literature,” J. Obstet. Gynaecol. (Lahore)., vol. 44, no. 1, 2024, doi: 10.1080/01443615.2023.2288225.
M. S. Ponomarenko, E. A. Reshetnikov, I. V Ponomarenko, and M. I. Churnosov, “RISK FACTORS FOR UTERINE FIBROIDS,” Akusherstvo i Ginekol. (Russian Fed., vol. 2024, no. 3, pp. 20–27, 2024, doi: 10.18565/aig.2023.275.
S. M. Hoy, “Take an individualized approach when managing women of reproductive age with uterine fibroids,” Drugs Ther. Perspect., vol. 40, no. 7, pp. 264–268, 2024, doi: 10.1007/s40267-024-01082-9.
A. Ahmad et al., “Diagnosis and management of uterine fibroids: current trends and future strategies,” J. Basic Clin. Physiol. Pharmacol., vol. 34, no. 3, pp. 291–310, 2023, doi: 10.1515/jbcpp-2022-0219.
R. B. Lasmar, B. P. Lasmar, S. G. Vitale, L. Mereu, and V. D. C. B. Xavier, “Uterine Fibroids and Endometrial Implications,” in Endometrium and Related Endouterine Pathologies: An Essential Examination for a Modern and Integrated Approach, 2025, pp. 49–76.
Y. Vilien, K. Dharmendra, M. Rajagopal, and M. Selvaraja, “Latest Evidence in the Pathogenesis of Uterine Fibroids,” Curr. Trends Biotechnol. Pharm., vol. 16, no. 2, pp. 260–287, 2022, doi: 10.5530/ctbp.2022.2.24.
Y. Dai et al., “Global and regional trends in the incidence and prevalence of uterine fibroids and attributable risk factors at the national level from 2010 to 2019: A worldwide database study,” Chin. Med. J. (Engl)., vol. 137, no. 21, pp. 2583–2589, 2024, doi: 10.1097/CM9.0000000000002971.
Z. Zhang, H. Huang, K. Jiang, W. Liu, Y. Xuan, and W. Lu, “Global, regional and national uterine fibroid burdens from 1990 to 2021 and projections until 2050: results from the GBD study,” BMC Womens. Health, vol. 25, no. 1, 2025, doi: 10.1186/s12905-025-03974-y.
W. Yan et al., “Status and treatment of patients with uterine fibroids in hospitals in central China: A retrospective study from 2018 to 2021,” BMJ Open, vol. 14, no. 1, 2024, doi: 10.1136/bmjopen-2023-081736.
M. M. Hassan, K. Naseem, and T. Akram, “17.Assessment Of Adverse Pregnancy Outcomes In Women With Uterine Fibroids At A Tertiary Hospital ,” Med. Forum Mon., vol. 32, no. 12, pp. 72–75, 2021, [Online]. Available: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125039057&partnerID=40&md5=411a51f426ead4dbce3bcd6f6a79e036.
N. Taj, S. Zafar, A. Mehvish, M. Munir, A. Ashfaq, and M. Siddiqui, “Evaluate the Assessment of Correlation of Uterine Fibroids with Adverse Pregnancy Outcomes: A Prospective Study,” Med. Forum Mon., vol. 33, no. 1, pp. 122–125, 2022, [Online]. Available: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129587483&partnerID=40&md5=8bb3a0eb009596fe507c844a0ef84d72.
T. S. Elhakim et al., “Disparities in Utilization of Uterine Fibroid Embolization,” JAMA Netw. open, vol. 8, no. 9, p. e2532100, 2025, doi: 10.1001/jamanetworkopen.2025.32100.
E. R. Knorren et al., “Treatment of Uterine Fibroid–Related Heavy Menstrual Bleeding: Variations in Clinical Practice at Four Hospitals in the Netherlands,” Obstet. Gynecol. Int., vol. 2026, no. 1, 2026, doi: 10.1155/ogi/2889686.
H. Najafiarab, F. Farzaneh, N. Talebian, Z. Ghasemi, and M. Talayeh, “Health-Related Quality of Life Among Iranian Women with Uterine Fibroids: A Cross Sectional Study,” J. Fam. Reprod. Heal., vol. 18, no. 3, pp. 164–169, 2024, doi: 10.18502/jfrh.v18i3.16658.
L. F. Wilson, K. M. Moss, J. Doust, C. M. Farquhar, and G. D. Mishra, “First Australian estimates of incidence and prevalence of uterine fibroids: A data linkage cohort study 2000-2022,” Hum. Reprod., vol. 39, no. 9, pp. 2134–2143, 2024, doi: 10.1093/humrep/deae162.
M.-M. Dolmans, F. Petraglia, W. H. Catherino, and J. Donnez, “Pathogenesis of uterine fibroids: current understanding and future directions,” Fertil. Steril., vol. 122, no. 1, pp. 6–11, 2024, doi: 10.1016/j.fertnstert.2024.02.048.
S. Vannuccini, V. Manzi, and F. Petraglia, “Uterine fibroids and infertility,” in Encyclopedia of Endocrine Diseases, vol. 1–5, 2026, p. Vol2:691-Vol2:700.
N. I. Hammadi, A. B. Radhi, M. J. Salih, and H. A. Abd-Al Sattar, “Histological features of uterine fibroids in relation to women’s age in Ramadi city,” J. Univ. Anbar Pure Sci., vol. 20, no. 1, pp. 138–145, 2026, doi: 10.37652/juaps.2025.160893.1414.
E. I. Obeagu, “Platelet-derived growth factor (PDGF) and its impact in fibroid pathogenesis A narrative review,” Med. (United States), vol. 104, no. 25, 2025, doi: 10.1097/MD.0000000000042995.
F. Farzaneh, S. H. Chayijan, H. N. Arab, F. R. Mansour, A. R. Keyvanfar, and Z. Bakhtiyari, “Clinical, Laboratory and Imaging Characteristics of Women with Uterine Fibroid: A Cross-Sectional Study from Iran,” J. Obstet. Gynecol. Cancer Res., vol. 9, no. 1, pp. 45–52, 2024, doi: 10.30699/jogcr.9.1.45.
Z. Lou et al., “Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study,” BMC Public Health, vol. 23, no. 1, 2023, doi: 10.1186/s12889-023-15765-x.
R. Muawad, R. Dabbagh, and Y. Sabr, “Association of health and lifestyle factors with uterine fibroids among Saudi women: A case–control study,” J. Taibah Univ. Med. Sci., vol. 17, no. 6, pp. 1039–1046, 2022, doi: 10.1016/j.jtumed.2022.06.005.
N. I. Babaeva et al., “FACTORS ASSOCIATED WITH UTERINE FIBROIDS IN WOMEN OF REPRODUCTIVE AGE: A CROSS-SECTIONAL STUDY,” Acta Biomed. Sci., vol. 9, no. 4, pp. 26–34, 2024, doi: 10.29413/ABS.2024-9.4.4.
A. Lach et al., “Health-Related Quality of Life, Anxiety, and Stress in Women with Uterine Fibroids: A Cross-Sectional Analysis,” J. Clin. Med., vol. 15, no. 12, 2026, doi: 10.3390/jcm15124777.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ferdinant Martinus Djawa, Elieser Elieser, Trajanus Laurens Jembise, Dais Iswanto
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
